跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
万珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bortezomib for Injection
Approved
化学药品
Bortezomib for Injection
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
May 6, 2022
Approval ID
8HTcEHfIGL9
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8HTcEHfIGL9
Approval Number
国药准字HJ20171086
Generic Name
注射用硼替佐米
Generic Name En
Bortezomib for Injection
Trade Name
万珂
Drug Type
化学药品
Dosage Form
注射剂
Strength
3.5mg
Reg Date
2022-05-06
Expired Date
2027-05-05
Company Name
Janssen-Cilag International NV
Production Company Name
BSP PHARMACEUTICALS SPA
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/bsp-pharmaceuticals-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 6, 2022
Approval ID
8HTcEHfIGL9
Type
化学药品
Back to NMPA Approvals